Steve Slovick
United States
T: +1 800 561 2380
Keiron Sparrowhawk
United Kingdom
T: +44 (0) 207 832 1086
Pressure on drugs’ value propositions are intense and increasing. Meeting these needs requires that evidence
from health economics and outcomes research is better integrated into the drug commercialization process.
PriceSpective's HEOR practice works with you to build and develop your value proposition with the highest quality research throughout your commercialization process. Our approach begins with a clear understanding
of the disease state and clinical positioning. Our team further brings to bear strong experience in drug
development and commercialization as well as deep expertise in research methods. Our team delivers a
strong value proposition and compelling evidence for payers throughout the product lifecycle.
Our core offerings reflect the central, strategic value the HEOR brings to the drug development and commercialization process.
Define Value Proposition
|
Generate and Communicate Evidence for Payers
|
Integration with Clinical Development
|
Development of forecasts that integrate geographic uptake and managed care uptake
|
Product Differentiation and Market Expansion
|
Identify New Opportunities
|

Our competitive advantage stems from the depth of our people’s experience across clinical, payer, commercial, and HEOR domains. We are thus able to develop innovative strategies and generate rigorous evidence to drive the value proposition of your products

Home | About us | Practices | Our approach | Thought leadership | Careers | Contact | Sitemap
T & C's Privacy policy Disclaimer © Copyright PriceSpective Ltd.